Hemophilia A Research Program (HARP) Education/ LinkedIn
Jul 22, 2026, 09:46
Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
Hemophilia A Research Program (HARP) Education shared a post on LinkedIn:
“The HARP mother-baby study in hemophilia is recruiting! Please help us get the word out!
Interested pregnant moms can go to HARP.
Providers can directly refer at: [email protected]
Flyers can also be downloaded at HARP Resources.
Hemophilia A Research Program (HARP) is looking to reach pregnant mothers anywhere in the U.S. Eligible moms have a genotype that causes hemophilia A (sometimes known as ‘carriers’) and a baby potentially at-risk for severe hemophilia A.
HARP is studying hemophilia bleeding risk in pregnancy and the causes of inhibitor formation in early childhood. To learn more visit HARP and Clinical Trials.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders